Furthermore, by changing the output protein to ghrelin (79) or progestins (80), the circuit might be applied to prevent cancer cachexia patients from experiencing significant whole-body lipolysis in the late stage of chemotherapy (81). This evidence concerns the gene GHRL and cancer.